Trial · NCT01584440
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Stage 1 (5 Weeks) | STARTED | Stage 1: AVP-923 | 93 | |
| Stage 1 (5 Weeks) | STARTED | Stage 1: Placebo | 127 | |
| Stage 1 (5 Weeks) | STARTED | AVP-923 in Stage 1/AVP-923 in Stage 2 | 0 | |
| Stage 1 (5 Weeks) | STARTED | Placebo in Stage 1/AVP-923 in Stage 2 | 0 | |
| Stage 1 (5 Weeks) | STARTED | Placebo in Stage 1/Placebo in Stage 2 | 0 | |
| Stage 1 (5 Weeks) | COMPLETED | Stage 1: AVP-923 | 83 | |
| Stage 1 (5 Weeks) | COMPLETED | Stage 1: Placebo | 119 | |
| Stage 1 (5 Weeks) | COMPLETED | AVP-923 in Stage 1/AVP-923 in Stage 2 | 0 | |
| Stage 1 (5 Weeks) | COMPLETED | Placebo in Stage 1/AVP-923 in Stage 2 | 0 | |
| Stage 1 (5 Weeks) | COMPLETED | Placebo in Stage 1/Placebo in Stage 2 | 0 | |
| Stage 1 (5 Weeks) | NOT COMPLETED | Stage 1: AVP-923 | 10 | |
| Stage 1 (5 Weeks) | NOT COMPLETED | Stage 1: Placebo | 8 | |
| Stage 1 (5 Weeks) | NOT COMPLETED | AVP-923 in Stage 1/AVP-923 in Stage 2 | 0 | |
| Stage 1 (5 Weeks) | NOT COMPLETED | Placebo in Stage 1/AVP-923 in Stage 2 | 0 | |
| Stage 1 (5 Weeks) | NOT COMPLETED | Placebo in Stage 1/Placebo in Stage 2 | 0 | |
| Stage 2 (5 Weeks) | STARTED | Stage 1: AVP-923 | 0 | |
| Stage 2 (5 Weeks) | STARTED | Stage 1: Placebo | 0 | |
| Stage 2 (5 Weeks) | STARTED | AVP-923 in Stage 1/AVP-923 in Stage 2 | 83 | |
| Stage 2 (5 Weeks) | STARTED | Placebo in Stage 1/AVP-923 in Stage 2 | 59 | |
| Stage 2 (5 Weeks) | STARTED | Placebo in Stage 1/Placebo in Stage 2 | 60 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01584440/flow